Compound Summary
Compound Information
3-Hydroxy-alpha-methyl-DL-tyrosine
Compound Name: | 3-Hydroxy-alpha-methyl-DL-tyrosine |
Compound CID: | 4138 |
Synonyms: | 3-Hydroxy-alpha-methyl-DL-tyrosine DL-Methyldopa 55-40-3 555-29-3 3-Hydroxy-alpha-methyltyrosine More... |
Iupac Name: | 2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid |
InChI: | InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15) |
InChIKey: | CJCSPKMFHVPWAR-UHFFFAOYSA-N |
Canonical Smiles: | CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N |
Isomeric Smiles: | CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N |
Molecular Weight: | 211.21 |
Molecular Formula: | C10H13NO4 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
3-Hydroxy-alpha-methyl-DL-tyrosine
Molecular Weight: | 211.21 |
Molecular Formula: | C10H13NO4 |
Hydrogen Bond Donor Count: | 4 |
Hydrogen Bond Acceptor Count: | 5 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 15 |
Complexity: | 246 |
Synonyms
3-Hydroxy-alpha-methyl-DL-tyrosine
| 3-Hydroxy-alpha-methyl-DL-tyrosine | 3-Hydroxy-alpha-methyl-DL-tyrosine |
|---|---|
3-Hydroxy-alpha-methyl-DL-tyrosine |
DL-Methyldopa |
55-40-3 |
555-29-3 |
3-Hydroxy-alpha-methyltyrosine |
Metholes |
Mulfasin |
DL-alpha-Methyl DOPA |
2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid |
(-)-Methyldopa |
Aldomin |
racemic alpha-Methyldopa |
(+-)-alpha-Methyldopa |
(+/-)-methyldopa |
.alpha.-Methyl dopa |
L-.alpha.-Methyldopa |
L-(.alpha.-Md) |
.alpha.-Methyl-L-dopa |
.alpha.-Methyldopa, L- |
EINECS 209-088-7 |
L-Tyrosine, 3-hydroxy-.alpha.-methyl- |
Dopamethyperpax |
Methoplain |
Aldometil |
Becanta |
Dopatec |
Dopegyt |
Grospisk |
Hypolag |
Medopal |
Medopren |
Presinol |
Sembrina |
Medopa |
L-Methyldopa |
(S)-(-)-.alpha.-Methyldopa |
Nr.C 2294 |
NCI-C55721 |
MK 351 |
(+/-)-3-(3,4-dihydroxyphenyl)-2-methyl-DL-alanine |
2-Methyl-3-(3,4-dihydroxyphenyl)alanine |
Bayer 1440 L |
.alpha.-Methyl-L-(3,4-dihydroxyphenyl)alanine |
L-.alpha.-Methyl-(3,4-dihydroxyphenyl)alanine |
.alpha.-Methyl-.beta.-(3,4-dihydroxyphenyl)-L-alanine |
ALANINE, 3-(3,4-DIHYDROXYPHENYL)-2-METHYL-, DL- |
L-(-)-.alpha.-Methyl-.beta.-(3,4-dihydroxyphenyl)alanine |
DL-Tyrosine, 3-hydroxy-alpha-methyl- (9CI) |
SR-01000075631 |
Aldomine |
Elanpres |
Equibar |
Lederdopa |
Methyl-dopa |
NSC169916 |
3-Hydroxy-.alpha.-methyl-L-tyrosine |
Methyldopa anhydrous, (+/-)- |
.alpha.-Medopa |
3,4-Dihydroxy-2-methylphenylalanine # |
NSC-169916 |
Methyldopa dl-form |
Tyrosine, 3-hydroxy-alpha-methyl- |
.alpha.-Methyldopa |
EINECS 200-232-4 |
Methyldopa (Racemic) |
DL-alpha-Methyl-DOPA |
3-(3,4-Dihydroxyphenyl)-2-methyl alanine |
(-)-.alpha.-Methyldopa |
CHEMBL718 |
Mk. b51 |
Lopac0_000770 |
SCHEMBL196981 |
WLN: QVXZ1&1R CQ DQ |
CHEBI:180994 |
HMS3259C21 |
HMS3262I22 |
HMS3266O08 |
2,2,3,4,4-PENTABDE |
ALBB-024010 |
BCP28393 |
Tox21_500770 |
SBB000508 |
AKOS003273681 |
AKOS017258656 |
AC-8433 |
CCG-204855 |
LP00770 |
MCULE-3456177599 |
NC00520 |
SDCCGSBI-0050748.P005 |
NCGC00015631-03 |
NCGC00015631-04 |
NCGC00015631-05 |
NCGC00015631-09 |
NCGC00094109-01 |
NCGC00094109-02 |
NCGC00261455-01 |
AC-11788 |
ST013867 |
SBI-0050748.P004 |
AB0012274 |
Alanine,4-dihydroxyphenyl)-2-methyl-, L- |
alpha-methyl-3,4-dihydroxy-dl-phenylalanine |
DB-018032 |
DB-052752 |
.alpha.-Methyl-L-3,4-dihydroxyphenylalanine |
EU-0100770 |
FT-0603468 |
FT-0604487 |
FT-0671717 |
FT-0671718 |
2-Methyl-3-(3,4-dihydroxyphenyl)-DL-alanine |
3-(3,4-dihydroxyphenyl)-2-methyl-DL-alanine |
M 7277 |
M-3586 |
Alanine,4-dihydroxyphenyl)-2-methyl-, L-(-)- |
555H293 |
A830691 |
L001029 |
SR-01000076007 |
(?)-3-(3,4-dihydroxyphenyl)-2-methyl-DL-alanine |
(y)-3-(3,4-dihydroxyphenyl)-2-methyl-DL-alanine |
Alanine, 3-(3,4-dihydroxyphenyl)-2-methyl-, L- |
SR-01000075631-1 |
SR-01000075631-3 |
SR-01000076007-1 |
W-105556 |
METHYLN-4-BOC-N-1-CBZ-2-PIPERAZINECARBOXYLATE |
Q27256299 |
2-amino-2-methyl-3-(3,4-dihydroxyphenyl)propionic acid |
L(-)-.beta.-(3,4-Dihydroxyphenyl)-.alpha.-methylalanine |
L-(-)-.beta.-(3,4-Dihydroxyphenyl)-.alpha.-methylalanine |
( inverted question mark)-3-(3,4-dihydroxyphenyl)-2-methyl-DL-alanine |
2-AMINO-3-(3,4-DIHYDROXY-PHENYL)-2- METHYL-PROPIONIC ACID(CATECHOL METABOLITE) |
Experimental Data
3-Hydroxy-alpha-methyl-DL-tyrosine
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 13 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
3-Hydroxy-alpha-methyl-DL-tyrosine
Statistics Data
3-Hydroxy-alpha-methyl-DL-tyrosine
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 13 | 1 | 1 |
Statistics Data Visualization
3-Hydroxy-alpha-methyl-DL-tyrosine
